Quantitative determination of the antitumor alkyl ether phospholipid edelfosine by reversed-phase liquid chromatography–electrospray mass spectrometry: application to cell uptake studies and characterization of drug delivery systems-Reference-Cited by-同舟云学术

Quantitative determination of the antitumor alkyl ether phospholipid edelfosine by reversed-phase liquid chromatography–electrospray mass spectrometry: application to cell uptake studies and characterization of drug delivery systems

Published:2004-10 Issue:1 Volume:810 Page:85-92
ISSN:1570-0232
Container-title:Journal of Chromatography B
language:en
Short-container-title:Journal of Chromatography B

Author:

Blanco-Príeto María J.,Campanero Miguel A.,Mollinedo Faustino

Publisher

Elsevier BV

Subject

Cell Biology,Clinical Biochemistry,Biochemistry,General Medicine,Analytical Chemistry

Reference21 articles.

1. Antitumoral and Other Biomedical Activities of Synthetic Ether Lysophospholipids (Part 1 of 2)

2. Analogs of alkyllysophospholipids: Chemistry, effects on the molecular level and their consequences for normal and malignant cells

3. Phospholipid antitumor agents

4. Biological Activities, Mechanisms of Action and Biomedical Prospect of the Antitumor Ether Phospholipid ET-18-OCH3 (Edelfosine), A Proapoptotic Agent in Tumor Cells

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis;Journal of Antimicrobial Chemotherapy;2012-07-24

2. Lipid raft-targeted therapy in multiple myeloma;Oncogene;2010-04-26

3. In vitro and In vivo Selective Antitumor Activity of Edelfosine against Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia Involving Lipid Rafts;Clinical Cancer Research;2010-03-16

4. Comparative study of A HPLC–MS assay versus an UHPLC–MS/MS for anti-tumoral alkyl lysophospholipid edelfosine determination in both biological samples and in lipid nanoparticulate systems;Journal of Chromatography B;2009-12

5. Antitumor Alkyl Ether Lipid Edelfosine: Tissue Distribution and Pharmacokinetic Behavior in Healthy and Tumor-Bearing Immunosuppressed Mice;Clinical Cancer Research;2009-02-01